KHN Morning Briefing

Summaries of health policy coverage from major news organizations

full issue

The Downstream Result Of Drug Shortages: Price Hikes For Similar Medications

In other drug-industry news, the Mayo Clinic's CEO joined Merck's board this week -- a role that he will have to navigate very carefully.

The Wall Street Journal: Prescription-Drug Shortages Help Push Up Prices Of Similar Drugs
Prescription-drug supply shortages have hurt U.S. medical care in recent years. According to new research, they’ve also caused another side effect—drug-price increases. A shortage of the bladder-cancer drug BCG in 2014 and 2015 led to sharp price increases for a less effective alternative treatment, mitomycin, according to research published online Wednesday by the New England Journal of Medicine. (Loftus, 4/12)

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.